Entheon Biomedical: Data and DMT among the keys to creating safe and effective treatments for patients battling addiction
Entheon Biomedical (CSE:ENBI) Chief Executive Officer Timothy Ko speaks passionately about his company and its objectives within the burgeoning psychedelics industry, not only because he heads one of the most dynamic teams in the space, but also because he credits psychedelics with saving his life. Following a childhood of challenges that continued into his adult…
